Surgicel®
Sponsors
Aesculap AG, Grifols Biologicals, LLC, Instituto Grifols, S.A., Ethicon, Inc., Cairo University
Conditions
Endometrial HyperplasiaEndometriomaHemorrhageHemostasisHepatic Parenchyma BleedingLiver HemorrhageParenchymous Tissue Surgical BleedingPeripheral Vascular Diseases
Phase 2
Phase 3
Safety and Efficacy of Fibrin Sealant Grifols (FS Grifols) During Soft Tissue Open Surgeries
CompletedNCT01731938
Start: 2012-11-30End: 2015-06-30Updated: 2017-02-23
Safety and Efficacy of Fibrin Sealant Grifols (FS Grifols) During Parenchymous Tissue Open Surgeries
CompletedNCT01754480
Start: 2013-03-31End: 2015-12-31Updated: 2017-02-08
The EVARREST® Paediatric Mild/Moderate Liver and Soft Tissue Bleeding Study
CompletedNCT02227992
Start: 2014-07-01End: 2021-11-12Updated: 2023-09-08
Traumastem® Versus Surgicel® for the Secondary Treatment of Local Bleeding in Patients Undergoing Hepatic Resection
CompletedNCT03489070
Start: 2017-08-15End: 2018-10-21Updated: 2018-10-23